Trovagene Investor Relations Trovagene Investor Relations Trovagene to Present at The MicroCap Conference on April 4, 2017 in New York City Mon, 27 Mar 2017 05:00:00 -0700 Trovagene to Present at the Sidoti & Company Spring 2017 Convention Tue, 21 Mar 2017 05:00:00 -0700 Trovagene Reports Fourth Quarter and Year End 2016 Financial Results Announces restructuring program to support its expansion into precision cancer therapeutics Wed, 15 Mar 2017 13:04:00 -0700 Trovagene and Nerviano Announce License Agreement for therapeutic candidate PCM-075 Wed, 15 Mar 2017 13:02:00 -0700 Trovera™ EGFR Urine Liquid Biopsy Test Predictive of Clinical Response to Therapy: Case Series in Patients with Non-Small Cell Lung Cancer Authors conclude that ctDNA testing demonstrates clinical utility in assessing disease burden and response to therapy Tue, 07 Mar 2017 05:00:00 -0800